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Introduction {#sec005}
============

Tuberculosis (TB) remains a major health problem worldwide \[[@pone.0181798.ref001]\]. Although the WHO global TB report showed that the global incidence of pulmonary TB (PTB) has reduced over time, the incidence of extrapulmonary-TB (EPTB) has increased to approximately 17% of all new and relapse cases of TB \[[@pone.0181798.ref002], [@pone.0181798.ref003]\]. Among the different types of emerging EPTB, tuberculous pleural effusion (TBPE) is one of the most common forms \[[@pone.0181798.ref004]--[@pone.0181798.ref006]\].

TBPE is definitively diagnosed by detection of *Mycobacterium tuberculosis* (MTB) in the pleural fluid or a biopsy specimen \[[@pone.0181798.ref005], [@pone.0181798.ref007]\]. In many cases, detection is considered difficult because of the paucibacillary characteristics of TBPE \[[@pone.0181798.ref006]\]. TB-PCR involving the Xpert MTB/RIF assay can be used to diagnose TBPE with high specificity, but this assay is limited by poor sensitivity \[[@pone.0181798.ref005], [@pone.0181798.ref007], [@pone.0181798.ref008]\]. Thus, in TB endemic areas, many cases of TBPE are clinically diagnosed based on the lymphocytic-predominant exudate and high adenosine deaminase (ADA) level in the pleural fluid \[[@pone.0181798.ref005], [@pone.0181798.ref006]\]. However, it is necessary to culture MTB from TBPE to enable clinicians to tailor the therapy, based on the drug-sensitivity test (DST). Moreover, EPTB can be caused by drug-resistant (DR) MTB, which shows a similar DR rate as PTB \[[@pone.0181798.ref009]\]. Recent advances in culturing methods, such as liquid media and microscopic-observation drug-susceptibility (MODS) culture, have led to an improvement in diagnostic ability. These culture methods are used to isolate MTB from clinical specimens, including pleural fluid \[[@pone.0181798.ref005], [@pone.0181798.ref010]--[@pone.0181798.ref012]\]. However, the diagnostic yield of MTB from TBPE patients is low in clinical practice \[[@pone.0181798.ref010], [@pone.0181798.ref012]--[@pone.0181798.ref014]\].

Conventionally, repeated sputum exams using consecutive specimens have been recommended to improve the efficiency of MTB detection in PTB \[[@pone.0181798.ref015]--[@pone.0181798.ref017]\], but there are no recommendations or policies for a similar situation in TBPE, although this process is more important for TBPE cultures without positive MTB from a respiratory specimen. No studies have examined the diagnostic efficacy of repeated pleural cultures for MTB.

This study was conducted to evaluate whether repeating pleural cultures for MTB improves the detection rate of MTB in TBPE, which has not been previously examined in clinical studies. In addition, we compared the differences between cases that were either culture-positive in the first and/or second pleural fluid specimen to identify any discriminating clinical, radiological, and pleural fluid factors, providing useful information to allow the clinician to determine which TBPE patients could be considered candidates for additional pleural cultures for MTB detection.

Methods {#sec006}
=======

Study population and design {#sec007}
---------------------------

We performed a retrospective review of patients diagnosed with TBPE in 4 hospitals of Hallym University Medical Center with \>600 beds in the Republic of Korea, an area of intermediate TB burden with a prevalence rate of 143/100,000 persons in 2013 \[[@pone.0181798.ref002]\]. Medical records between January 2012 and December 2015 were obtained.

During the study period, all consecutive patients aged \>18 years who had been diagnosed with TBPE were screened. The exclusion criteria were patients: 1) who had received anti-TB treatment before the first pleural culture (this can affect the cultivation rate of TBPE with paucibacillary characteristics); 2) who had TBPE combined with microbiologically confirmed PTB (this was defined as culture-positive MTB in respiratory specimens, despite no radiological evidence of PTB). These cases were excluded for two reasons. First, the original aim of this study was to develop a new method for improving culture yield for MTB in TBPE. Second, the revised WHO guidelines recommend that combined PTB and TBPE should be classified as PTB \[[@pone.0181798.ref018]\].); 3) with a history of previously treated TB (which may confuse the presence of combined PTB or loculated features of TBPE); 4) with positive acid-fast bacilli (AFB) smear for TBPE, because these cases do not typically require repeated pleural culture for MTB, as MTB is easily isolated and not the subject of our study. Enrolled cases were classified into 2 groups according to the number of pleural cultures for MTB: single vs. repeated pleural culture group.

The protocol for this study was approved by the Institutional Review Board of each participating hospital (Kangdong Sacred Heart Hospital, Hallym University Sacred Heart Hospital, Kangnam Sacred Heart Hospital and Chuncheon Sacred Heart Hospital) for the review and publishing of information from the patients' records. Informed consent was waived because of the retrospective nature of the study.

Diagnosis of TBPE {#sec008}
-----------------

TBPE was diagnosed based on the following criteria: (1) culture-positivity for MTB or positive TB-polymerase chain reaction (PCR) in pleural fluid or tissue; (2) granulomatous inflammation in pleural tissue; (3) pleural fluid combined with PTB resolved with anti-TB treatment; (4) lymphocytic exudates with high ADA levels (\>40 U/L) in the pleural fluid, with cytological examination negative for malignancy and pleural effusion cleared by anti-TB treatment \[[@pone.0181798.ref005], [@pone.0181798.ref006]\].

Thoracentesis and microbiologic examination {#sec009}
-------------------------------------------

Fifty-milliliters of pleural fluid specimens was obtained during thoracentesis, collected in sterile polypropylene tubes, and transported to the laboratory. Of these, 5 mL of pleural fluid was concentrated, but not decontaminated, and inoculated for MTB culture as recommended \[[@pone.0181798.ref019]\]. AFB smears were prepared by auramine---rhodamine fluorescence staining and confirmed by Ziehl-Neelsen staining. MTB cultures were simultaneously performed with solid media, 3% Ogawa media (Eiken Chemical, Tokyo, Japan), and liquid media in the mycobacteria growth indicator tube 960 system (BD Biosciences, Franklin Lakes, NJ, USA).

Statistical analysis {#sec010}
--------------------

The data are presented as the median and interquartile range (IQR) for continuous variables and numbers (percentage) for categorical variables. The diagnostic consistency according to the number of pleural cultures was analyzed by McNemar's test. To identify factors for predicting MTB growth in TBPE, clinical, radiological, and laboratory characteristics based on the positivity of the first and/or second pleural culture were compared by the Kruskal-Wallis test for continuous variables and the Chi-square test for categorical variables. The Wilcoxon test was performed to compare differences in pleural fluid biochemistry between the first and second thoracentesis. Multiple logistic regression analysis was performed to identify independent predictors of cultivation of MTB, as measured by the estimated odds ratios (OR) with 95% confidence intervals (CI), including variables with a *P*-value \< 0.2 on univariate analysis. To reduce the risk of multicollinearity, one closely correlated variable was included as a candidate in the final model. All tests were two-sided and a P-value of less than 0.05 was considered statistically significant. Data were analyzed using IBM SPSS Statistics, version 24 (IBM, Armonk, NY, USA).

Results {#sec011}
=======

Of the 4029 patients with TB from 2012 to 2015, 678 were diagnosed with TBPE. We excluded patients who received anti-TB treatment before the first pleural culture (n = 18), exhibited concurrent PTB (n = 255), had a history of treatment for TB (n = 46), or had a positive AFB smear for TBPE (n = 13) ([Fig 1](#pone.0181798.g001){ref-type="fig"}). In addition, we excluded 17 cases where the time interval between the first and second cultures was more than 3 days, as the goal of this study was to determine the diagnostic potential of the second culture \[[@pone.0181798.ref015]--[@pone.0181798.ref017]\].

![Flowchart of study: Selection of study participants.](pone.0181798.g001){#pone.0181798.g001}

A total of 329 TBPE cases were included and analyzed, including 109 culture-positive and 220 culture-negative cases for MTB in TBPE. Of the 220 patients who were culture-negative for MTB in TBPE, 14 were diagnosed by pleural biopsy, while 206 were diagnosed based on clinical criteria. Of the 329 total cases of TBPE, 252 cases provided a single pleural specimen for MTB culture, while the other 77 provided repeated pleural cultures.

The main focus of this study is the repeated-culture group, and the demographic and descriptive data of the 77 cases in this group are summarized in [Table 1](#pone.0181798.t001){ref-type="table"}. There were 52 male subjects (67.5%) with a median age of 49.0 (IQR, 34.5--70.0) years. Among the 77 cases in the repeated-culture group, loculated TBPE was identified in 36 cases (46.8%) and the time interval between the first and second pleural cultures was a median of 1 day (1.0--2.0).

10.1371/journal.pone.0181798.t001

###### Baseline characteristics of 329 patients with TBPE.

![](pone.0181798.t001){#pone.0181798.t001g}

                                                     Single culture            Repeated culture         *P*-value
  -------------------------------------------------- ------------------------- ------------------------ -----------
  Age, years                                         46.0 (29.3--66.8)         49.0 (34.5--70.0)        0.4
  Male gender, %                                     138 (54.8)                52 (67.5)                0.049
  Time interval between first and second culture     NA                        1 (1.0--2.0)             NA
  Comorbidity                                                                                           
   COPD and asthma                                   15 (6.0)                  4 (5.2)                  0.989
   Chronic liver disease                             3 (1.2)                   1 (1.3)                  0.999
   Diabetes                                          28 (11.1)                 13 (16.9)                0.235
   Cerebrovascular disease                           8 (3.2)                   6 (7.8)                  0.103
   Cardiovascular disease                            12 (4.8)                  6 (7.8)                  0.388
   Hypertension                                      43(16.7)                  19 (24.7)                0.182
   CKD                                               6 (2.4)                   5 (6.5)                  0.138
   Rheumatic disease                                 5 (2.0)                   4 (5.2)                  0.222
   Malignancy[\*](#t001fn003){ref-type="table-fn"}   0                         6 (7.8)                  \<0.001
  Radiological feature of TBPE                                                                          
   Loculation                                        93 (36.9)                 36 (46.8)                \<0.001
   Amount†                                                                                              
    Large                                            43 (17.1)                 12 (15.6)                0.395
    Moderate                                         176 (69.8))               59 (76.6)                
    Small                                            33 (13.1)                 6 (7.8)                  
   Effusion site                                                                                        
    Right                                            138 (54.8)                44 (57.1)                0.794
    Left                                             114 (45.2)                33 (42.9)                
  Pleural fluid                                                                                         
   Overall MTB culture-positive                      75 (29.8)                 34 (44.2)                \<0.001
    only in first culture                                                      9 (11.7)                 
    only in second culture                                                     10 (13.0)                
    in both first and second culture                                           15 (19.5)                
   MTB-PCR positive                                  3 (1.2)                   5 (6.5)                  0.019
   SG                                                1.038 (1.036--1.040)      1.038 (1.034--1.040)     0.339
   WBC (total cells)                                 2160.0 (1085.0--4120.0)   1860.0 (572.5--3425.0)   0.138
    Lymphocyte, %                                    80.0 (64.3--90.0)         79.0 (58.0--90.0)        0.747
    Neutrophil, %                                    10.0 (3.5--20.0)          6.0 (2.0--34.0)          0.985
   pH                                                7.363 (7.313--7.411)      7.368 (7.282--7.413)     0.316
   Glucose (mg/dL)                                   88.0 (73.0--111.5)        85.0 (66.5--107.5)       0.444
   Protein (g/dL)                                    5.2 (4.7--5.6)            5.1 (4.5--5.5)           0.272
   Albumin (g/dL)                                    2.9 (2.6--3.2)            2.8 (2.4--3.1)           0.12
   LDH (IU/L)                                        523.5 (351.8--811.8)      587.0 (452.8--998.5)     0.13
   ADA (IU/L)                                        86.7 (71.2--102.9)        84.4 (65.9--110.6)       0.494

Data are presented as the number of patients (%) or median (IQR)

TBPE, tuberculous pleural effusion; IQR, interquartile range; NA, not applicable; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; MTB, *Mycobacterium tuberculosis*; PCR, polymerase chain reaction; WBC, white blood cell; SG, specific gravity; LDH, lactate dehydrogenase; ADA, adenosine deaminase

\*Prostate cancer (n = 1), ovary cancer (n = 1), bladder cancer (n = 1), rectal cancer (n = 1), gastric carcinoid (n = 1) and renal cell carcinoma (n = 1)

Diagnostic yield from single and repeated pleural cultures for MTB {#sec012}
------------------------------------------------------------------

In the single-culture group, 29.8% (75/252) of the cases were culture-positive for MTB in TBPE. In the repeated-culture group, MTB was cultured from 31.2% (24/77) of the cases on the first pleural culture, which did not significantly differ from the results of the single-culture group (*P* = 0.887). However, the second pleural culture showed 13.0% (10/77) greater yield of MTB than did the first MTB culture trial. In the repeated-culture group, 44.2% (34/77) of cases eventually yielded a positive culture for MTB ([Table 1](#pone.0181798.t001){ref-type="table"}). Finally, the diagnostic yield of MTB in TBPE was significantly increased by the second pleural culture in the repeated-culture group (31.1% vs. 44.2%, *P* \< 0.001). Among the 34 MTBs isolated from the repeated-culture group, the DST suggested that pathogens were susceptible to all except four anti-TB drugs. Three isolates were resistant to INH only and one isolate was resistant to isoniazid and para-aminosalicylic acid.

However, the increase in MTB yield via second pleural culture decreased over several days from 17.4% to 6.7% and eventually to 6.3% when the time interval between the first and second culture was increased ([Fig 2](#pone.0181798.g002){ref-type="fig"}). The median total white blood cell count and neutrophil percentage showed decreasing trends over time, but the lymphocyte percentage increased. However, the differences were not significant.

![Positive culture rate of overall and second pleural culture according to time interval between first and second culture and changes in pleural fluid characteristics.](pone.0181798.g002){#pone.0181798.g002}

Biochemical changes in TBPE in sequential examinations {#sec013}
------------------------------------------------------

[Table 2](#pone.0181798.t002){ref-type="table"} shows the biochemical changes in sequential examinations of the 77 cases in the repeated pleural culture group between the first and second pleural tappings. Even though lymphocyte predominance persisted, the proportion of neutrophils increased in culture-positives group only in the second culture or remained the same in culture-positive groups in both cultures. In contrast, lymphocyte predominance persisted and the proportion of neutrophils decreased in culture-positive group only in the first culture and culture-negative group in both cultures.

10.1371/journal.pone.0181798.t002

###### Biochemical changes in sequential examinations of 77 cases in the repeated pleural culture group.

![](pone.0181798.t002){#pone.0181798.t002g}

                                                          First tapping             Second tapping           
  ------------------------------------------------------- ------------------------- ------------------------ -------
  Positive MTB in both pleural cultures (n = 15)                                                             
  WBC (total cells)                                       1320.0 (291.0--3750.0)    1730.0 (575--7720)       0.248
   Lymphocyte, %                                          81.0 (54.8--93.5)         66.0 (46.3--94.0)        0.656
   Neutrophil, %                                          7.5 (1.8--45.8)           19.0 (2.8--47.0)         0.799
  Positive MTB only in first pleural culture (n = 9)                                                         
  WBC (total cells)                                       2120.0 (1775.0--4685.0)   795.0 (272.0--1890.0)    0.017
   Lymphocyte, %                                          54.0 (16.5--71.0)         79.0 (48.8--89.5)        0.068
   Neutrophil, %                                          35.0 (11.5--64.0)         10.5 (4.8--31.3)         0.063
  Positive MTB only in second pleural cultures (n = 10)                                                      
  WBC (total cells)                                       460 (183.8--2165.0)       570.0 (277.5--2062.5)    0.735
   Lymphocyte, %                                          81.5 (59.3--88.5)         80.0 (29.5--91.3)        0.326
   Neutrophil, %                                          5.0 (1.0--30.0)           17.0 (5.0--47.3)         0.036
  No MTB growth in both pleural culture (n = 43)                                                             
  WBC (total cells)                                       2130.0 (685.0--3450.0)    1225.0 (357.5--5267.5)   0.517
   Lymphocyte, %                                          81.5 (60.8--92.3)         81.0 (65.80--95.8)       0.352
   Neutrophil, %                                          5.5 (1.0--20.8)           4.5 (1.3--15.0)          0.619

Data are presented as median (IQR)

MTB, *Mycobacterium tuberculosis*; WBC, white blood cell

Predictors for MTB-positive cultures of first and second pleural culture {#sec014}
------------------------------------------------------------------------

Univariate comparisons of the clinical, radiological, and laboratory data of 77 TBPE patients with repeated pleural cultures are presented in [Table 3](#pone.0181798.t003){ref-type="table"}. When samples were grouped into culture-positive from the first pleural culture, culture-positive only from the second pleural culture, and no growth from either pleural culture, there were no significant differences except for loculation, positive MTB-PCR, and lactate dehydrogenase (LDH) level.

10.1371/journal.pone.0181798.t003

###### Comparisons of clinical, radiological, and laboratory characteristics based on MTB culture-positivity of serial pleural fluid in 77 TBPE patients.

![](pone.0181798.t003){#pone.0181798.t003g}

                                                            Positive in first culture   Positive only in second culture   No growth                *P*-value
  --------------------------------------------------------- --------------------------- --------------------------------- ------------------------ -----------
  Age, years                                                49.0 (34.5--68.3)           45.5 (31.0--73.75)                51.0 (35.0--70.0)        0.893
  Male gender, %                                            14 (58.3)                   8 (80.0)                          30 (69.8)                0.42
  Time interval between first and second culture            1.0 (1.0--3.0)              1.0 (1.0--1.3)                    1.0 (1.0--2.0)           0.34
  Comorbidity                                                                                                                                      
   COPD and asthma                                          1 (4.2)                     0                                 3 (7.0)                  0.645
   Chronic liver disease                                    1 (4.2)                     0                                 0                        0.327
   Diabetes                                                 2 (8.3)                     2 (20.0)                          9 (20.9)                 0.402
   Cerebrovascular disease                                  2 (8.3)                     0                                 4 (9.3)                  0.609
   Cardiovascular disease                                   2 (8.3)                     1 (10.0)                          3 (7.0)                  0.943
   Hypertension                                             6 (25.0)                    4 (40.0)                          9 (20.9)                 0.452
   CKD                                                      2 (8.3)                     1 (10.0)                          2 (4.7)                  0.75
   Rheumatic disease[\*](#t003fn003){ref-type="table-fn"}   1 (4.2)                     2 (20.0)                          1 (2.3)                  0.073
   Malignancy                                               2 (8.3)                     1 (10.0)                          3 (7.0)                  0.943
  Radiological features of TBPE                                                                                                                    
   Loculation                                               20 (83.3)                   8 (80.0)                          8 (18.6)                 \<0.001
    Amount[†](#t003fn004){ref-type="table-fn"}                                                                                                     
     Large                                                  2 (8.3)                     1 (10.0)                          9 (20.9)                 0.213
     Moderate                                               18 (75.0)                   9 (90.0)                          32 (74.4)                
     Small                                                  4 (16.7)                    0 (0.0)                           2 (4.7)                  
    Effusion site                                                                                                                                  
     Right                                                  13 (54.2)                   6 (60.0)                          25 (58.1)                0.934
     Left                                                   11 (45.8)                   4 (40.0)                          18 (41.9)                
  Pleural fluid, first thoracentesis                                                                                                               
   MTB-PCR positive                                         4 (16.7)                    1 (10.0)                          0                        0.026
   SG                                                       1.038 (1.035--1.040)        1.040 (1.026--1.042)              1.038 (1.034--1.040)     0.842
   WBC (total cells)                                        1855.0 (590.0--3732.5)      460.0 (183.8--2165.0)             2130.0 (685.0--3450.0)   0.083
    Lymphocyte, %                                           65.0 (50.0--90.0)           81.5 (59.3--88.5)                 81.5 (60.8--92.3)        0.354
    Neutrophil, %                                           20.0 (3.0--58.0)            5.0 (1.0--30.0)                   5.5 (1.0--20.8)          0.099
   pH                                                       7.338 (7.224--7.394)        7.266 (7.227--7.392)              7.394 (7.301--7.428)     0.046
   Glucose (mg/dL)                                          78.0 (54.0--106.8)          87.0 (46.0--134.5)                95.0 (74.0--108.0)       0.186
   Protein (g/dL)                                           5.1 (4.7--5.4)              5.5 (3.0--5.7)                    5.2 (4.5--5.4)           0.721
   Albumin (g/dL)                                           2.9 (2.5--3.1)              2.8 (1.4--3.2)                    2.8 (2.3--3.1)           0.786
   LDH (IU/L)                                               778.5 (553.3--1185.0)       555.0 (398.5--1265.0)             529.0 (360.0--899.0)     0.02
   ADA (IU/L)                                               93.4 (72.2--106.2)          84.3 (36.6--125.6)                81.6 (66.3--111.4)       0.853
  Pleural fluid, second thoracentesis                                                                                                              
   WBC (total cells)                                        1440.0 (467.0--3375.0)      570.0 (277.5--2062.5)             1225.0 (357.5--5267.5)   0.343
   Lymphocyte, %                                            70.5 (47.0--93.3)           80.0 (29.5--91.3)                 81.0 (65.80--95.8)       0.275
   Neutrophil, %                                            17.5 (5.3--34.4)            17.0 (5.0--47.3)                  4.5 (1.3--15.0)          0.047

Data are presented as the number of patients (%) or median (IQR)

TBPE, tuberculous pleural effusion; IQR, interquartile range; NA, not applicable; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; MTB, *Mycobacterium tuberculosis*; PCR, polymerase chain reaction; WBC, white blood cell; SG, specific gravity; LDH, lactate dehydrogenase; ADA, adenosine deaminase

\*Gout (n = 3), Sjogren syndrome (n = 1) and rheumatoid arthritis (n = 1)

^†^The amount of TBPE was classified as small, moderate, or large based on the following findings on chest radiographs prior to pleural tapping: (1) small, a level of TBPE that blunted the costophrenic angle but did not obscure the entire diaphragm; (2) moderate, a level that obscured the entire diaphragm but was below the hilum; (3) large, a level up to and above the hilum.

To identify clinical predictors of MTB cultivation in TBPE after the first and second pleural culture, further multivariate logistic regression was conducted. In the first culture trial, the loculation of TBPE (adjusted OR, 14.967; 95% CI, 3.595--62.314; *P* \< 0.001) and neutrophil percentage (adjusted OR, 1.031; 95% CI, 1.001--1.062; *P* \< 0.001) were independently associated with culture-positivity for MTB in TBPE, after adjusting for potential confounding factors with P-values less than 0.2 in univariate analysis. In the second culture trial, the loculation of TBPE (adjusted OR, 5.799; 95% CI, 1.488--22.549; *P* = 0.011) and neutrophil percentage (adjusted OR, 1.039; 95% CI, 1.003--1.076; *P* \< 0.001) were independently associated with the cultivation of MTB in the same manner ([Table 4](#pone.0181798.t004){ref-type="table"}).

10.1371/journal.pone.0181798.t004

###### Predictors of MTB cultivation in patients with tuberculous pleural effusion via first and second pleural culture.

![](pone.0181798.t004){#pone.0181798.t004g}

                                                 Univariate analyses      Multivariate logistic regression analyses                            
  ---------------------------------------------- ------------------------ ------------------------------------------- ------------------------ ---------
  **First pleural culture for MTB isolation**                                                                                                  
  Rheumatic disease                              10.932 (0.244−489.436)   0.218                                                                
  Loculated TBPE                                 17.123 (3.501−83.745)    \<0.001                                     14.061 (3.503--56.447)   \<0.001
  Pleural fluid                                                                                                                                
   MTB-PCR positive                              13.677 (0.286−654.824)   0.083                                                                
   Lymphocyte, %                                 1.061 (0.969−1.162)      0.203                                                                
   Neutrophil, %                                 1.114 (0.991−1.251)      0.070                                       1.031 (1.001--1.062)     0.041
   pH                                            0.084 (0.012−0.064)      0.185                                                                
   Glucose (mg/dL)                               0.993 (0.967−1.020)      0.600                                                                
   LDH (IU/L)                                    1.000 (0.998−1.002)      0.980                                                                
  **Second pleural culture for MTB isolation**                                                                                                 
  Rheumatic disease                              0.251 (0.020−3.138)      0.283                                                                
  Loculated TBPE                                 6.032 (1.514−26.239)     0.011                                       5.799 (1.488--22.549)    0.011
  Pleural fluid                                                                                                                                
   Lymphocyte, %                                 1.061 (0.969−1.162)      0.202                                                                
   Neutrophil, %                                 1.117 (0.993−1.257)      0.064                                       1.039 (1.003--1.076)     0.034
   Toward lymphocyte predominance                0.866 (0.184−4.082)      0.856                                                                
   Toward neutrophil predominance                0.572 (0.130−2.521)      0.308                                                                

TBPE, tuberculous pleural effusion; MTB, *Mycobacterium tuberculosis*; PCR, polymerase chain reaction; LDH, lactate dehydrogenase

Discussion {#sec015}
==========

In this study, we evaluated whether repeated pleural cultures are associated with increased MTB growth from pure TBPE, excluding cases with combined PTB or positive AFB smear for TBPE. This study revealed important findings regarding the culture of MTB in TBPE. First, the yield of MTB from TBPE patients increased by approximately 13% if pleural cultures were repeated ([Table 1](#pone.0181798.t001){ref-type="table"}). Second, the additional isolation of MTB via second pleural culture decreased over time. Thus, the effect of second pleural culture may be maximized when it is conducted for 2 days in a row. These results may be related to the insufficient immune clearance for invading of MTB into the pleural space ([Table 2](#pone.0181798.t002){ref-type="table"} and [Fig 2](#pone.0181798.g002){ref-type="fig"}). This result can be applied for MTB isolation in TBPE and a continuous spectrum of disease processes. Moreover, the loculation and neutrophil percentage of TBPE were positively associated with the probability of MTB culture from TBPE ([Table 4](#pone.0181798.t004){ref-type="table"}). Thus, the association between additional culture-positivity for MTB and biochemical changes of TBPE was determined in this study. This is the first study to evaluate the diagnostic value of additional pleural cultures for identifying MTB.

Unlike the traditional concept of pathogenesis of TBPE, which involves a delayed hypersensitivity response of TB protein, it is now considered a spectrum, with the occurrence of direct MTB infection into the pleural space followed by serial immunological reactions to clear the pathogen \[[@pone.0181798.ref005], [@pone.0181798.ref020]\]. Thus, the possibility of MTB cultivation is increased if there is insufficient immunological clearance. We observed interesting results when we compared the biochemical characteristics of TBPE. In cases where both pleural cultures were positive, the proportion of neutrophils remained constant over time even though lymphocyte predominance persisted. Moreover, the proportion of neutrophils increased culture-positives group only in the second culture. In contrast, lymphocyte predominance continued, and the proportion of neutrophils decreased in cases where both pleural cultures were negative, as well as cases where only the first pleural culture was positive.

This new concept of TBPE pathogenesis allows for the identification of predictors of MTB cultivation. Previous studies have reported that low lymphocyte percentage, high neutrophil percentage, low glucose and pH levels, and high LDH level of TBPE, which suggest ongoing inflammation, are associated with MTB culture in TBPE \[[@pone.0181798.ref004], [@pone.0181798.ref013], [@pone.0181798.ref021], [@pone.0181798.ref022]\]. Moreover, loculation of TBPE is well-known as an intense intra-pleural inflammation and clinical predictor of MTB culture \[[@pone.0181798.ref023]--[@pone.0181798.ref025]\]. Similarly, loculation and a high neutrophil percentage were independently associated with culture-positivity for MTB in TBPE in our study.

Conventionally, pleural biopsy and culture of tissue are considered the most accurate modalities for diagnosis of TB pleuritis. Despite advances in ultrasonography-guided and thoracoscopic pleural biopsy, this method remains invasive with fatal complication risks \[[@pone.0181798.ref005], [@pone.0181798.ref006], [@pone.0181798.ref026]\]. Moreover, in TB endemic areas including South Korea, TB pleurits is conducted according to clinical, radiological, and laboratory findings, except for complex cases.

Thus, several studies have been carried out to develop a more effective method for isolating MTB from TBPE \[[@pone.0181798.ref004], [@pone.0181798.ref012]--[@pone.0181798.ref014]\]. Previous studies have shown that liquid media culture and MODS culture resulted in greater MTB growth as compared to solid media culture \[[@pone.0181798.ref011], [@pone.0181798.ref012]\]. Moreover, MTB identification was improved when a combination of solid and liquid media was used as compared to using only one type of media \[[@pone.0181798.ref013], [@pone.0181798.ref027]\]. However, additional methods are needed to increase the growth of MTB because much of the TBPE remains in the gray zone. Interestingly, a recent study showed that a larger volume culture of TBPE improved the growth of MTB, but this was less effective than expected \[[@pone.0181798.ref014]\]. Therefore, we attempted to develop other methods for increasing culture yield.

In the diagnosis of PTB, the WHO recommends repeating more than two sputum cultures for MTB culture, based on the diagnostic yield of consecutive microbiological exams \[[@pone.0181798.ref015]\]. On this basis, we presumed that repeated pleural cultures would also improve the growth of MTB. We excluded cases with combined PTB and TBPE or positive AFB smear for TBPE, because MTB as a pathogen is easy to isolate in these cases and does not typically require additional effort such as repeated pleural culture for MTB \[[@pone.0181798.ref004], [@pone.0181798.ref028]\]. The goal of this study was to develop a method for isolating MTB in only TBPE within the grey-zone of culture-negativity for MTB. Therefore, repeating the pleural culture of TBPE was expected to improve MTB growth in clinical practice. The diagnostic yield of this method should be evaluated particularly in specimens from patients with TBPE without PTB and positive AFB smear for TBPE \[[@pone.0181798.ref029]\]. In this study of patients with TBPE only, repeated pleural cultures showed 13% (10/77) greater MTB growth overall. Furthermore, the yield of second cultures decreased over time from 17.4% to 6.7% to eventually 6.3%, similar to that in previous sputum studies \[[@pone.0181798.ref016]\].

In this study, we conducted repeated pleural cultures over a 3-day period because this was a retrospective observational study. In South Korea, an intermediate TB-burden country, clinicians prescribe anti-TB medication after identifying pleural fluid characteristics such as lymphocytic exudates with high ADA levels (\>40 U/L) before microbiological confirmation of MTB, which is based on the Korea Guidelines for Tuberculosis. In academic hospitals, pleural fluid characteristics, including pleural CEA for differentiating from malignancy, are reported within 1 day. However, cytological examination results are typically reported within 2--3 days. Thus, most TBPE cases are administered anti-TB medication on the same day of thoracentesis, the first pleural culture for MTB. Moreover, TBPE is a paucibacillary disease and therefore, accuracy can be decreased and the results will be less informative if the time interval between the first and second pleural cultures is extended. For PTB, repeated sputum exams using specimens obtained over 3 consecutive days have been recommended in many guidelines. Thus, we limited the time frame of the second culture to a 3-day period.

There were several limitations to this study. First, the results of this study were based on retrospective data and a relatively small sample size in the repeated-culture group, despite being conducted in multiple centers. Thus, we cannot definitively conclude that the repeated pleural culture increases the isolation of MTB by up to 13.0% in all TBPE cases. However, because the goal of this study was to improve the diagnostic yield from cases of TBPE alone, we classified MTB culture-positive respiratory specimens as PTB regardless of evidence of radiological involvement of lung parenchyma, unlike in a previous study \[[@pone.0181798.ref029]\]. As described in the introduction, the aim of this study was to develop a method for reducing the grey-zone in TBPE diagnosis through microbiological confirmation. Therefore, we excluded 24 TBPE cases with MTB culture-positive respiratory specimens, although these subjects had provided a second pleural culture and had no radiological evidence of PTB.

Second, clinical decisions to collect second pleural cultures were based on the clinical features of TBPE patients and the actual yield of MTB growth may be biased. Since 2012, some pulmonologists in our medical centers have conducted inter-costal drainage by inserting a pig-tail tube in suspected TBPE cases when possible. This was carried out either for effective drainage or reduction of residual pleural thickening with or without fibrinolysis therapy, particularly in cases with loculated TBPE. Moreover, we conducted additional pleural fluid culture for MTB isolation for 2 consecutive days. Repeated pleural cultures were performed on different days. This protocol was applied for most cases (69/77, 89.6%) in this study. In the remaining 8 cases of TBPE, additional pleural culture was conducted during repeated thoracentesis for symptom relief.

Third, this study showed a relatively low rate of culture-positive TBPE compared to the rate outside South Korea (109/329, 33.1% vs. 50.0% to 63.1%) \[[@pone.0181798.ref004], [@pone.0181798.ref014]\]. However, most studies in Korea showed a similar culture-positive rate (15.0--41.3%). It should be noted that some of the other studies included cases of TBPE with PTB \[[@pone.0181798.ref004], [@pone.0181798.ref013], [@pone.0181798.ref014], [@pone.0181798.ref023], [@pone.0181798.ref030]\]. Fourth, this study was performed in an area with an intermediate TB rate and low human immunodeficiency virus (HIV) infection burden. There were no HIV-infected cases enrolled in our study or included in the analysis. Thus, our results may not be generalized to other clinical situations, and further studies are needed in order to determine whether these results can be applied.

Conclusions {#sec016}
===========

In conclusion, repeated pleural cultures yielded increased cultures of MTB from TBPE in HIV-negative individuals and were particularly effective when conducted for 2 consecutive days. This suggests that repeated pleural cultures are advantageous for isolating MTB from specimens of patients with TBPE without PTB and positive AFB smear for TBPE, for which no other simple methods for culture growth can be used.
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ADA

:   adenosine deaminase

AFB

:   acid-fast bacilli

CKD

:   chronic kidney disease

COPD

:   chronic obstructive pulmonary disease

DR

:   drug-resistant

DST

:   drug sensitivity test

EPTB

:   extrapulmonary tuberculosis

HIV

:   human immunodeficiency virus

IQR

:   interquartile range

LDH

:   lactate dehydrogenase

MTB

:   *Mycobacterium tuberculosis*

NA

:   not applicable

PCR

:   polymerase chain reaction

PTB

:   pulmonary tuberculosis

SG

:   specific gravity

TB

:   tuberculosis

TBPE

:   tuberculous pleural effusion

WBC

:   white blood cell

WHO

:   World Health Organization
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